WO2003043565A3 - Methodes de diagnostic et de traitement de maladies associees a l'expression modifiee de nrf2 - Google Patents
Methodes de diagnostic et de traitement de maladies associees a l'expression modifiee de nrf2 Download PDFInfo
- Publication number
- WO2003043565A3 WO2003043565A3 PCT/IB2002/005830 IB0205830W WO03043565A3 WO 2003043565 A3 WO2003043565 A3 WO 2003043565A3 IB 0205830 W IB0205830 W IB 0205830W WO 03043565 A3 WO03043565 A3 WO 03043565A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- diagnosis
- treatment
- nrf2
- methods
- diseases associated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002364889A AU2002364889A1 (en) | 2001-09-24 | 2002-09-24 | Methods for diagnosis and treatment of diseases associated with altered expression of nrf2 |
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/962,916 | 2001-09-24 | ||
US09/962,854 US20030044803A1 (en) | 2000-09-22 | 2001-09-24 | Methods for diagnosis and treatment of diseases associated with altered expression of JAK1 |
US09/962,854 | 2001-09-24 | ||
US09/962,855 US20020164576A1 (en) | 2000-09-22 | 2001-09-24 | Methods for diagnosis and treatment of diseases associated with altered expression of Nrf2 |
US09/962,929 US20020115058A1 (en) | 2000-09-22 | 2001-09-24 | Methods for diagnosis and treatment of diseases associated with altered expression of Pik3r1 |
US09/963,131 US20030224460A1 (en) | 2000-09-22 | 2001-09-24 | Novel compositions and methods for lymphoma and leukemia |
US09/963,131 | 2001-09-24 | ||
US09/962,855 | 2001-09-24 | ||
US09/962,929 | 2001-09-24 | ||
US09/962,916 US20030077590A1 (en) | 2000-09-22 | 2001-09-24 | Methods for diagnosis and treatment of diseases associated with altered expression of neurogranin |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003043565A2 WO2003043565A2 (fr) | 2003-05-30 |
WO2003043565A3 true WO2003043565A3 (fr) | 2003-11-13 |
Family
ID=27542309
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2002/004158 WO2003027321A2 (fr) | 2001-09-24 | 2002-09-24 | Methodes de diagnostic et de traitement de maladies associees a une expression alteree de neurogranine |
PCT/IB2002/004123 WO2003027320A2 (fr) | 2001-09-24 | 2002-09-24 | Methodes de diagnostic et de traitement de maladies associees a l'expression modifiee de pik3r1 |
PCT/IB2002/005830 WO2003043565A2 (fr) | 2001-09-24 | 2002-09-24 | Methodes de diagnostic et de traitement de maladies associees a l'expression modifiee de nrf2 |
PCT/IB2002/004134 WO2003027276A2 (fr) | 2001-09-24 | 2002-09-24 | Nouvelles compositions et procedes relatifs aux lymphomes et aux leucemies |
PCT/IB2002/004197 WO2003027295A2 (fr) | 2001-09-24 | 2002-09-24 | Procedes de diagnostic et de traitement de maladies associees a l'expression alteree de la jak1 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2002/004158 WO2003027321A2 (fr) | 2001-09-24 | 2002-09-24 | Methodes de diagnostic et de traitement de maladies associees a une expression alteree de neurogranine |
PCT/IB2002/004123 WO2003027320A2 (fr) | 2001-09-24 | 2002-09-24 | Methodes de diagnostic et de traitement de maladies associees a l'expression modifiee de pik3r1 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2002/004134 WO2003027276A2 (fr) | 2001-09-24 | 2002-09-24 | Nouvelles compositions et procedes relatifs aux lymphomes et aux leucemies |
PCT/IB2002/004197 WO2003027295A2 (fr) | 2001-09-24 | 2002-09-24 | Procedes de diagnostic et de traitement de maladies associees a l'expression alteree de la jak1 |
Country Status (2)
Country | Link |
---|---|
AU (4) | AU2002364889A1 (fr) |
WO (5) | WO2003027321A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1959969A2 (fr) * | 2005-07-01 | 2008-08-27 | The Johns Hopkins University | Compositions et procedes pour traiter ou prevenir des troubles associes au stress oxydatif |
KR20090019767A (ko) * | 2006-02-14 | 2009-02-25 | 더프레지던트앤드펠로우즈오브하바드칼리지 | 유사분열 진행 유전자 및 유사분열을 조절하는 방법 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999041985A1 (fr) * | 1998-02-23 | 1999-08-26 | Quark Biotech, Inc. | Secretion de facteurs inhibiteurs de croissance dependant de p53 |
WO1999065928A2 (fr) * | 1998-06-19 | 1999-12-23 | Genzyme Corporation | Population de polynucleotides isoles de tissus mammaires tumoraux metastatiques ou non metastatiques |
WO2001057189A2 (fr) * | 2000-02-07 | 2001-08-09 | Quark Biotech, Inc. | Genes de la voie fas |
WO2001096390A2 (fr) * | 2000-06-09 | 2001-12-20 | Corixa Corporation | Compositions et procedes pour la therapie et le diagnostic du cancer du colon |
WO2002020849A2 (fr) * | 2000-09-08 | 2002-03-14 | New York University | Marqueurs de gene utiles pour detecter des lesions de la peau dues au rayonnement ultraviolet |
WO2002020846A2 (fr) * | 2000-09-08 | 2002-03-14 | New York University | Methodes de criblage pour identifier des composes modulant une reponse d'une cellule a l'exposition a un rayonnement ultraviolet |
WO2002022884A2 (fr) * | 2000-09-12 | 2002-03-21 | Transgenetics Incorporated | Organisation en micro-reseaux de genes cibles de facteur de transcription |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ237669A (en) * | 1990-04-13 | 1992-08-26 | Res Dev Foundation | T-cell proteins expressed in t-cell development and their preparation |
US5821069A (en) * | 1993-06-30 | 1998-10-13 | Ludwig Institute For Cancer Research | Method for determining tyrosine kinase in a sample |
US6300058B1 (en) * | 1992-01-29 | 2001-10-09 | Hitachi Chemical Research Center, Inc. | Method for measuring messenger RNA |
WO1997003358A1 (fr) * | 1995-07-07 | 1997-01-30 | The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Procede pour identifier des inhibiteurs de la voie de transduction de signaux jak-stat |
WO1998016557A1 (fr) * | 1996-10-11 | 1998-04-23 | The General Hospital Corporation | Dosages pour recepteurs lies a la proteine g |
JP2000506396A (ja) * | 1996-11-01 | 2000-05-30 | オニックス ファーマシューティカルズ,インコーポレイティド | ホスファチジルイノシトール―3′―キナーゼ関連タンパク質をコードするヌクレオチド配列及びその利用 |
AU742342B2 (en) * | 1997-05-21 | 2001-12-20 | Clontech Laboratories, Inc. | Nucleic acid arrays |
US5994076A (en) * | 1997-05-21 | 1999-11-30 | Clontech Laboratories, Inc. | Methods of assaying differential expression |
WO1999038972A2 (fr) * | 1998-01-28 | 1999-08-05 | Chiron Corporation | Genes humains et produits ii d'expression genique |
DE19817947A1 (de) * | 1998-04-17 | 1999-10-28 | Metagen Gesellschaft Fuer Genomforschung Mbh | Menschliche Nukleinsäuresequenzen aus Myometrium-Tumorgewebe |
IL139080A0 (en) * | 1998-04-17 | 2001-11-25 | Parker Hughes Inst | Btx inhibitors and methods for their indentification and use |
US6100090A (en) * | 1999-06-25 | 2000-08-08 | Isis Pharmaceuticals Inc. | Antisense inhibition of PI3K p85 expression |
JP2002536963A (ja) * | 1998-12-22 | 2002-11-05 | ミリアド・ジェネティックス・インコーポレイテッド | 神経変性疾患におけるタンパク質−タンパク質相互作用 |
US6110664A (en) * | 1999-06-25 | 2000-08-29 | Isis Pharmaceuticals Inc. | Antisense inhibition of G-alpha-S1 expression |
GB9917165D0 (en) * | 1999-07-22 | 1999-09-22 | Knoll Ag | Polypeptides polynuclcotides and uses thereof |
ATE309241T1 (de) * | 1999-09-10 | 2005-11-15 | Merck & Co Inc | Tyrosin kinase inhibitoren |
CA2389834A1 (fr) * | 1999-10-25 | 2001-05-03 | Monica Mody | Sequences genetiques associees a la proliferation et aux pathologies des cellules neuronales |
AU1760201A (en) * | 1999-11-12 | 2001-06-06 | Fred Hutchinson Cancer Research Center | Methods for treatment of human huntington's disease and methods of screening foractive agents |
WO2001051670A2 (fr) * | 2000-01-07 | 2001-07-19 | Curagen Corporation | Acides nucleiques renfermant des polymorphismes de nucleotide simple et procede d'utilisation associe |
DE60144277D1 (de) * | 2000-04-25 | 2011-05-05 | Icos Corp | Hemmer der menschlichen phosphatidyl-inositol-3-kinase delta |
KR100830859B1 (ko) * | 2000-04-27 | 2008-05-21 | 아스텔라스세이야쿠 가부시키가이샤 | 이미다조피리딘 유도체 및 이를 함유하는 의약 조성물 |
AU2001290965A1 (en) * | 2000-09-13 | 2002-03-26 | Archemix Corporation | Target activated nucleic acid biosensor and methods of using same |
WO2002040637A2 (fr) * | 2000-11-20 | 2002-05-23 | Isis Pharmaceuticals, Inc. | Modulation antisens de l'expression de pi3k p85 |
WO2002059367A2 (fr) * | 2000-11-30 | 2002-08-01 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Jeu de microechantillons de diagnostic pour ibd, maladie de crohn et colite ulcereuse |
CA2436487A1 (fr) * | 2001-01-30 | 2002-08-08 | Cytopia Pty Ltd. | Procedes d'inhibition de kinases |
AUPR279101A0 (en) * | 2001-01-30 | 2001-02-22 | Cytopia Pty Ltd | Protein kinase signalling |
US20020137086A1 (en) * | 2001-03-01 | 2002-09-26 | Alexander Olek | Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylation status of the genes |
AU2002330039A1 (en) * | 2001-09-17 | 2003-04-01 | Eos Biotechnology, Inc. | Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer |
GB0122914D0 (en) * | 2001-09-22 | 2001-11-14 | Univ Nottingham | Modulation of stat activity |
-
2002
- 2002-09-24 WO PCT/IB2002/004158 patent/WO2003027321A2/fr not_active Application Discontinuation
- 2002-09-24 AU AU2002364889A patent/AU2002364889A1/en not_active Abandoned
- 2002-09-24 WO PCT/IB2002/004123 patent/WO2003027320A2/fr not_active Application Discontinuation
- 2002-09-24 WO PCT/IB2002/005830 patent/WO2003043565A2/fr not_active Application Discontinuation
- 2002-09-24 WO PCT/IB2002/004134 patent/WO2003027276A2/fr not_active Application Discontinuation
- 2002-09-24 WO PCT/IB2002/004197 patent/WO2003027295A2/fr not_active Application Discontinuation
- 2002-09-24 AU AU2002337442A patent/AU2002337442A1/en not_active Abandoned
- 2002-09-24 AU AU2002330713A patent/AU2002330713A1/en not_active Abandoned
- 2002-09-24 AU AU2002329000A patent/AU2002329000A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999041985A1 (fr) * | 1998-02-23 | 1999-08-26 | Quark Biotech, Inc. | Secretion de facteurs inhibiteurs de croissance dependant de p53 |
WO1999065928A2 (fr) * | 1998-06-19 | 1999-12-23 | Genzyme Corporation | Population de polynucleotides isoles de tissus mammaires tumoraux metastatiques ou non metastatiques |
WO2001057189A2 (fr) * | 2000-02-07 | 2001-08-09 | Quark Biotech, Inc. | Genes de la voie fas |
WO2001096390A2 (fr) * | 2000-06-09 | 2001-12-20 | Corixa Corporation | Compositions et procedes pour la therapie et le diagnostic du cancer du colon |
WO2002020849A2 (fr) * | 2000-09-08 | 2002-03-14 | New York University | Marqueurs de gene utiles pour detecter des lesions de la peau dues au rayonnement ultraviolet |
WO2002020846A2 (fr) * | 2000-09-08 | 2002-03-14 | New York University | Methodes de criblage pour identifier des composes modulant une reponse d'une cellule a l'exposition a un rayonnement ultraviolet |
WO2002022884A2 (fr) * | 2000-09-12 | 2002-03-21 | Transgenetics Incorporated | Organisation en micro-reseaux de genes cibles de facteur de transcription |
Non-Patent Citations (8)
Title |
---|
ALIZADEH A A ET AL: "DISTINCT TYPES OF DIFFUSE LARGE B-CELL LYMPHOMA IDENTIFIED BY GENE EXPRESSION PROFILING", NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, vol. 403, 3 February 2000 (2000-02-03), pages 503 - 512, XP002943414, ISSN: 0028-0836 * |
BLOOD, vol. 94, no. 10 SUPPL. 1 PART 2, 15 November 1999 (1999-11-15), Forty-first Annual Meeting of the American Society of Hematology;New Orleans, Louisiana, USA; December 3-7, 1999, pages 140b, ISSN: 0006-4971 * |
CHAN KAIMIN ET AL: "NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 93, no. 24, 1996, 1996, pages 13943 - 13948, XP002251107, ISSN: 0027-8424 * |
CHENAIS BENOIT: "Requirement of GATA-1 and p45 NF-E2 expression in butyric acid-induced erythroid differentiation.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 253, no. 3, 30 December 1998 (1998-12-30), pages 883 - 886, XP002251109, ISSN: 0006-291X * |
CHUI DAVID H K ET AL: "CDNA cloning of murine Nrf 2 gene, coding for a p45 NF-E2 related transcription factor.", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 209, no. 1, 1995, pages 40 - 46, XP002934232, ISSN: 0006-291X * |
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 15 November 1999 (1999-11-15), LEHNHARDT ANJA ET AL: "Expression of fNF-E2 mRNA, but not aNF-E2-mRNA correlates with GATA-1 mRNA and NF-E2 p45 protein expression in leukemic cell lines and in primary cells.", XP002251108, Database accession no. PREV200000046601 * |
MOI P ET AL: "Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 91, no. 21, 1994, 1994, pages 9926 - 9930, XP002964572, ISSN: 0027-8424 * |
RAMOS-GOMEZ M ET AL: "Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 13 MAR 2001 UNITED STATES, vol. 98, no. 6, 13 March 2001 (2001-03-13), pages 3410 - 3415, XP002251110, ISSN: 0027-8424 * |
Also Published As
Publication number | Publication date |
---|---|
WO2003027320A3 (fr) | 2003-10-23 |
AU2002364889A1 (en) | 2003-06-10 |
WO2003027295A2 (fr) | 2003-04-03 |
AU2002330713A1 (en) | 2003-04-07 |
AU2002337442A1 (en) | 2003-04-07 |
WO2003027321A3 (fr) | 2003-11-06 |
WO2003027276A2 (fr) | 2003-04-03 |
AU2002364889A8 (en) | 2003-06-10 |
WO2003027321A2 (fr) | 2003-04-03 |
WO2003043565A2 (fr) | 2003-05-30 |
WO2003027320A2 (fr) | 2003-04-03 |
WO2003027276A3 (fr) | 2004-02-12 |
WO2003027295A3 (fr) | 2003-10-16 |
AU2002329000A1 (en) | 2003-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003008583A3 (fr) | Nouvelles compositions et methodes relatives au cancer | |
EP2014669A3 (fr) | Procédés et compositions de lutte contre le cancer | |
WO2004006858A3 (fr) | Composes, compositions et methodes d'utilisation de ces derniers | |
WO2005027966A3 (fr) | Anticorps aux fonctions d'effecteur modifiees | |
WO2003000200A3 (fr) | ss-2'-OU 3'-HALONUCLEOSIDES | |
WO2003066661A3 (fr) | Anticorps humains du dr4 et utilisations | |
UA85559C2 (en) | Aminobenzophenone compounds | |
TW200505875A (en) | Novel compounds | |
GB0111186D0 (en) | Novel compounds | |
ZA200409492B (en) | Compositions and methods for the diagnosis and treatment of tumor. | |
AU2003300368A1 (en) | Methods and compositions for the diagnosis, prognosis, and treatment of cancer | |
WO2003045230A3 (fr) | Compositions et procedes contre le cancer | |
WO2001017543A3 (fr) | Compositions et procedes permettant la prevention ou le traitement du cancer et de la perte osseuse associee au cancer | |
WO2003057146A3 (fr) | Compositions et procedes concernant le cancer | |
WO2000066528A3 (fr) | Novel quinones utilisees dans le traitements de maladies | |
WO2002094189A3 (fr) | Compositions et procedes de traitement ou de prevention de convulsions ou de crises | |
WO2005051288A3 (fr) | Compositions apportant des benefices a la peau a l'aide d'intermediaires metaboliques cellulaires cle | |
WO2002081745A3 (fr) | Genes impliques dans l'osteogenese et procedes d'utilisation associes | |
WO2003053224A3 (fr) | Nouvelles compositions et methodes contre le cancer | |
WO2002024867A3 (fr) | Nouvelles compositions et nouvelles methodes pour le diagnostic et le traitement des lymphomes et des leucemies | |
WO2003045324A3 (fr) | 14-methyl-epothilones | |
WO2003035837A3 (fr) | Nouvelles compositions et procedes relatifs au cancer | |
WO2003039484A3 (fr) | Nouvelles compositions et methodes pour le traitement du cancer | |
WO2003071933A3 (fr) | Nouvelles compositions et procedes de traitement du cancer | |
WO2003043565A3 (fr) | Methodes de diagnostic et de traitement de maladies associees a l'expression modifiee de nrf2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LU MC NL PT SE SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |